Sustainability Performance (SP) contributions are critical for corporate profit when considering long-term economic growth, but they also impose additional financial constraints for many firms. This thesis examines the association amid pharmaceutical firms' SP and corporate performance (CP) using data from 150 pharmaceutical listed companies from 2016 to 2020. Furthermore, corporate social responsibility (CSR) is classified as environmental, social, and governance in order to investigate its moderating influence on SP and CP. SP appears to have a favorable and considerable influence on CP in pharmaceutical listed companies. According to the findings, a higher social pillar score (SPS) can accelerate the good effect of SP on CP. Furthermore, in terms of region, the American faction surpasses the other factions regarding sustainability and corporate performance. These findings give theoretical and practical benchmarks for CSR managem
